chrisvoncsefalvay/vaers-outcomes huggingface dataset:
received booster from expired vial; Chiils; Fatigue; This spontaneous case was reported by a physician and describes the occurrence of CHILLS (Chiils), FATIGUE (Fatigue) and EXPIRED PRODUCT ADMINISTERED (received booster from expired vial) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Bacitracin allergy), Drug allergy (Lidocaine allergy), Allergy to antibiotic (polysporin allergy), GERD, High cholesterol and Hyperlipidemia. Concomitant products included SIMVASTATIN for Hyperlipidemia, ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]) for Reflux esophagitis.    On 29-Oct-2021 at 1:10 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 ml. In 2021, the patient experienced CHILLS (Chiils) and FATIGUE (Fatigue). On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received booster from expired vial). In 2021, CHILLS (Chiils) and FATIGUE (Fatigue) had resolved. On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (received booster from expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.   The adverse events lasted for 24 hours.   Most recent FOLLOW-UP information incorporated above includes: On 05-Nov-2021: follow up received contains updated reporter type, patient demographic details, medical history, added concomitant medications and added events
Pt vaccinated with Engerix-B fullness in ears, flushing sensation head & face, weakness in the arm, both ears became itchy, both ears became red hot occurred one month ago following first injection.
Woke up at 2 am Sunday morning after having the injection Saturday evening with severe chills, body ache,  headache and nausea started getting a cough late Sunday  which has turned into congestion and a cough and a tightness in my chest.
Information has been received from a health professional concerning a patient (12 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
I experienced intramuscular soreness at site of influenza vaccine along with minor muscle spams in forearm and upperarm. I then started experiencing numbness on the dorsal side of my thumb.
I started having sharp pains in my right triceps.; achy; tired; had a sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN (achy), FATIGUE (tired), VACCINATION SITE PAIN (had a sore arm) and PAIN IN EXTREMITY (I started having sharp pains in my right triceps.) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 077C21B, 016C21A and 505C21A) for COVID-19 prophylaxis.     Patient had no allergies, cardiac issues or COVID-19 history.  Previously administered products included for Product used for unknown indication: COVID-19 VACCINE JANSSEN (Lot: 1805020 and Site: left arm) on 08-Mar-2021. Past adverse reactions to the above products included No adverse reaction with COVID-19 VACCINE JANSSEN.   On 28-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jun-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Dec-2021, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Dec-2021, the patient experienced PAIN (achy), FATIGUE (tired) and VACCINATION SITE PAIN (had a sore arm). On an unknown date, the patient experienced PAIN IN EXTREMITY (I started having sharp pains in my right triceps.). At the time of the report, PAIN (achy), FATIGUE (tired), VACCINATION SITE PAIN (had a sore arm) and PAIN IN EXTREMITY (I started having sharp pains in my right triceps.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging normal: normal normal. On an unknown date, X-ray limb: normal normal.         Vaccine administration site was right shoulder. No concomitant medication was reported. In March or April 2022 patient had sharp pains in right triceps. Patient was doing physical therapy, but it's not helping.   This case was linked to MOD-2022-587494, MOD-2022-587535 (Patient Link).
employee reports fever, headache, sore throat, loss of voice, extreme fatigue, nausea and vomiting for 2 days following immunization, states husband tested positive for covid 11/13/21, she tested negative on binax rapid test 11/15/21
Patient reported difficulty swallowing and metallic taste in mouth within 15 minutes of vaccination.  BP 175/120.  Patient was transported to ER by EMS.
Severe worsening of headache beginning 6 days after vaccination.  Prior to vaccination the patient reports having frequent headaches that were treated with daily doses of ibuprofen.  She had presented to my office on 3/31/2021 with complaint of abdominal discomfort and I suspected this was related to her overuse of ibuprofen.  I asked her to stop taking the ibuprofen And did prescribe Fioricet to be used as needed for headaches if she were to have them in the future.  She contact my office on 4/2/2021 saying that she has had severe worsening of headaches for the last 2 days previous and this continued with severe daily headache for weeks.  This resulted in multiple trips to the emergency room and even an inpatient
Parent previously declined administration of Rotateq vaccine at 2 and 4 mos. Physicals 1st dose of this vaccine given at 6 months of age contrary to manufacturer's recommendation. No side effects/problems/adverse reactions reported by parent.
both shots and still got them; still got them; less painful; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles and pain.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The reporter was the patient's friend. The age at vaccination was not reported. The reporter stated that, he/she thought shingles vaccine was supposed lessen the severity and not make it worse. The reporter stated that, the patient got both the Shingles shots and still got the shingles but ere less painful then what she had before the shots. This case was considered as suspected vaccination failure, since the details regarding the time to onset for event and laboratory confirmation for shingles were not provided.
Myalgia, arthralgia at shoulders and between shoulder to neck. 04/14/2002 no treatment to date.
Patient received her 1st dose of the Pfizer vaccine at our clinic at the time stated above. She was observed for 30 minutes and sent home, per protocol. At 12N, she left the building and began heading to her car.  Patient's family member brought her back inside as patient was experiencing intermittent jerking movements of her entire upper body, mainly focused on her abdomen, chest and shoulders. Vitals were obtained, Pt was AAOx4, BP 165/69, P61, R21, Pulse Ox 98%. At 1202, 911 was called as patient stated she has a lengthy history of allergies to medicines and foods. At 1206, 50 mg PO of Benadryl were given without complication. Patient stated she had discussed getting the vaccine with her allergy physician.
Heavy menstrual bleeding, passing very large clots, painful periods, cycle is shortened to 23-24 days. 7 mos later symptoms are still occurring.
LOW INTERNATIONAL NORMALISED RATIO (INR); This spontaneous report received from a patient concerned a 72 year old male. The patient's weight was 240 pounds, and height was 72 inches.  The patient's past medical history included strokes at 42 and 44 years of age, and grande mal seizure at age 44 with stroke, and concurrent conditions included primary antiphospholipid antibody syndrome, blood thinners for 30 years, non-smoker, social alcohol drinker, artificial aortic valve after first stroke at age 42, and pacemaker, and other pre-existing medical conditions included the patient did not have any history of drug abuse or illicit drug use. the patient's father and brother had primary antiphospholipid antibody syndrome (pps) both was deceased and his nephew recently discovered that he also have had primary antiphospholipid antibody syndrome (pps). the patient's father died at age 60 and his brother died at age 73 from primary antiphospholipid antibody syndrome (pps).  The patient experienced drug allergy when treated with phenytoin.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. Concomitant medications included warfarin sodium.  On 2021, the subject experienced low international normalised ratio (inr). Laboratory data included: INR (NR: not provided) 3.4, 2.0. On 03-MAY-2021, Laboratory data included: INR (NR: not provided) 2.5. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from low international normalised ratio (inr). This report was non-serious.; Sender's Comments: V0: Medical assessment comments not required as per the standard procedure as the case is assessed as non-serious.
11-29-2010 Pt c/o severe sore throat, body aches, chills, fever x 2 days, cough and chest congestion. Tested (+) for influenza A/B "Binax".
50 cent size red hot lump at injection site that evening. By morning thigh was red. He was still active and wasn't complaining of it. By today reaction site was improved.
Face numbness began 25 minutes following injection, and extreme pain in left jaw, neck, shoulder and arm, very loud tinnitus also started same day; approximately one week later, began experiencing numbing and tingling in face around nose, cheeks, lips, and tongue, and both forearms and hands, and both legs below the knees and feet; numbing/tingling feeling and tinnitus ongoing for over six weeks and continues as of this report.
EXPIRED VACCINE USED; This spontaneous report received from a health care professional concerned an adult female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: 19-SEP-2021) dose was not reported, administered on SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On SEP-2021, the patient experienced expired vaccine used. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine used was not reported. This report was non-serious.
Headache, NauseaVomiting, chills, fatigue, arm soreness Narrative:
shortness of breath and a little cough , FEVER, VOMITING, GENERALIZED BODY ACHES
PATIENT RECEIVED VACCINE ON 10/20/2021 PATIENT STATES 24 HRS LATER SHE HAD FEVER AND FLU SYPTOMS AND ON FRIDAY 10/22/2021 SHE HAD SWELLING OF LYMPH NODES TO THE RT ARM AND ALSO HAD CHEST PAIN  THAT WENT DOWN TO THE LEFT ARM, SHE WENT TO THE ER AT A DIFFERENT FACILITY TO GET CHECKED AND SHE STATES THEY DID LAB WORK.  SHE SCHEDULED AN OFFICE VISIT HERE AT THE MEDICAL CLINIC ON WED 11/03/2021 WITH COMPLAINTS OF BREAST PAIN AND STATES SHE HAS HAD THE PAIN FOR THE LAST 7 DAYS.
8 doses given today after vial was punctured 30May2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (8 doses given today after vial was punctured 30May2021) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (8 doses given today after vial was punctured 30May2021). On 01-Jun-2021, EXPIRED PRODUCT ADMINISTERED (8 doses given today after vial was punctured 30May2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Technician states that 8 doses of vaccine were administered on 30-may-2021 with Lot  049C21A 5Nov2021.   No concomitant medication was reported.   The treatment information was not given.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021 at 1:53 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 29-Oct-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  It was reported that the vaccine was at frozen storage condition at the time of the temperature excursion. Excursion duration was 1 month. On 29-Oct-2021, the Moderna COVID-19 vaccine vial went from the super cold freezer to the refrigerator. The vaccine was returned to the freezer/refrigerator/ultra cold freezer, or maintained at room temperature. No vaccine state changes were noticed. The vaccine was never refrozen. None of the vials were punctured. No previous temperature excursion issues had happened. The patient was given doses from a vial that were stored in an ultracold freezer which is colder than they should have been.  No treatment medication information was provided.   This case was linked to MOD-2021-402935 (Patient Link).
Flu symptoms including chills, fever, body aches, sore at injection site, swelling under left arm pit area started and lasted the following day.  Headache lasted 2 days.  Extremely tired lasted 2 days.  Took shot Friday at 1:00pm, Didn?t feel better til Monday 4:00am after taking 1 dose of Tylenol on Sunday at 7pm.
Pt's mother states that the pt received 4 vaccines on 01/28/2002, two in each leg. She is unsure which vaccines were administered to each legs but pt's right leg was light red. His left leg has "more redness and warm to touch and swelling bumps where the shots were given." His temp. 99.6 deg. F and is using Tylenol
Covid breakthrough. I didn't get too sick so I thought I had a mild case. I had a fever of 101.5-102 degrees. I felt off, I didn't have a cough. I had severe pain across my back almost like childbirth pain also in my shoulders. After 4 hours, I took Advil which helped a lot. Feeling sick lasted about a day so I thought I had a mild case. I noticed a couple days later I noticed I couldn't taste at all. Since then I have been having 24/7 heart palpitations. Its constant fluttering, it feels like its rolling instead of beating. I've been having a lot of brain fog. I am scheduled for an ECG next week after months of trying to schedule an appointment. I started going to acupuncture a month ago and it seems to be the only thing that has helped. Everything seems to improved a little bit. I am able to taste 50 percent and my heart sometimes feels okay since the acupuncture. I am still scared 80 percent of the time, its maybe a 20 percent improvement in my heart. I also have been very fatigued.
Immediately after the shot my arm bleed out more than a normal shot would had caused. (Bandage was soaked with blood). Within hours my Arm began to get sore. By the next day sever redness, swelling, whelps, and hot heat radiated on right arm that lasted 4 days the size of a grapefruit. After the third day of shot I also developed abdominal pain in lower abdomen, the pain was so intense it caused issues with walking upright.  I also noticed my urine appeared dark in amber color even though I only drank water. This abdominal pain lasted three days with bloating and gas. It's been 10 days since vaccine, abdomen pain is gone,  however the injection site still has large purple bruising from shot.  I am concerned about getting second dose vaccine due to above reactions. I've contacted my health doctor for advice.
Information has been received from a registered nurse concerning her daughter, a 22 year old female patient who in approximately 2008 (reported as approximately a year and half ago) was vaccinated with the first dose of GARDASIL (lot number, route and site not reported). The nurse reported that the patient was not a patient at the office she worked at. In approximately 2008 (reported as approximately a year and half ago), the patient experienced swelling of the lymph nodes on the left side of her neck and she did not feel really well. Then the patient received the second dose of GARDASIL and after receiving the second dose of GARDASIL, the lymph nodes on her left side of her neck got bigger and were the size of a golf ball. The patient had seen physician to seek medical attention. The nurse reported that the patient has now recovered and was not going to receive the third dose of GARDASIL. Additional information is not expected.
Client staes that the day after (12/4) she received her booster shot her left lymph-node in the armpit swelled up and has been very tender, to the point of not being able to put her arm down. Today (12/6) the client states that some of the swelling has gone down but the tenderness is still there.
12/24/2020 started mild cough, still coughing, sneezing, no fever.
Continuous, radiating pain from upper arm starting 3 to 4 days after immunization.  Patient presented to the pharmacy on 8/09/22 wearing an arm sling and reports that he is having an operation on 8/11/22 for a ruptured bicep.
Janssen COVID-19 Vaccine EUA  Cough and wheezing persisting 6 days after vaccination (still present). Fever and chills for one day after vaccination (now gone).
Pfizer-BioNTech COVID-19 Vaccine EUA  Loose stools: 1/22-1/25 Sore throat: 1/25, 1/26 Feeling unwell: 1/26 Fatigue: 1/26
cough; feeling tired; chills; muscle pain; fatigue; This is a spontaneous report from a Pfizer sponsored program. This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), dose 2 via an unspecified route of administration on 25Feb2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced chills, muscle pain and fatigue on 26Feb2021, cough and feeling tired on an unspecified date. Therapeutic measures were taken as a result of muscle pain (She added that she took 2 pills of painkillers). Outcome of all the events was unknown except muscle pain which was recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Pityriasis rosea; Small patches of rash trailing from my neck down my abdomen.; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in right arm on 08Apr2021 at 14:30 (at the age of 21-years old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Apr2021, the patient had experienced and she small ovular blemish on the inside of the right arm, just under the elbow crease. The patient thought it was a burn but she was diagnosed at a clinic with pityriasis rosea, the mark on her arm being the herald and she have small patches of rash trailing from her neck down the abdomen. The events resulted in a visit to the doctors or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse event, which included calamine lotion and allergy medication. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, pityriasis rosea and small patches of rash trailing from her neck down the abdomen was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Severe pain in both shoulders and arms; Severe pain in both shoulders and arms; This pain is so great, it keeps me awake at night; This is a spontaneous report from a contactable consumer (patient). This 86-year-old consumer of an unspecified gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 12Feb2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation.  Relevant medical history and concomitant medications were not reported. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 22Jan2021 for COVID-19 immunisation. One week after the second dose, in Feb2021, the patient developed severe pain in both shoulders and arms. This pain was so great, it kept the patient awake at night, and if he/she got to sleep, it woke him/her up. The patient tried to get relief by "rubbing" all day and taking Tylenol Extra Strength (2 tablets every 6 hours as prescribed). This slightly helped, but it was very temporally. The pain was so great, it was difficult to pick up a cup of coffee. The outcome of the events was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.